With a market capitalization (market cap) of $179.47B — a measure of how much the company is worth — Gilead Sciences, Inc. ranks #83 among the 2,510 companies tracked, and 10th in Healthcare as of October 3, 2026. Shares trade at $144.74, down 1.87% on the day.
of 2,510 tracked